ASAM/ACMT Addiction Toxicology Case Conference Webinar Series

5 (1 vote)

  • Register
    • Non-Member - Free!
    • Regular Member - Free!
    • Retired - Free!
    • Early Career Physician - Free!
    • Resident - Free!
    • Student - Free!
    • Associate - Free!
    • ASAM Staff - Free!
    • International Member - Free!
    • Emeritus Member - Free!
    • Provisional Member - Free!
    • Fellow Member - Free!
    • Honorary Member - Free!
    • CRT Member - Free!

ASAM/ACMT Addiction Toxicology Case Conference Webinar Series

On-Demand Webinars

Overview

This free series of live and on-demand webinars occurs on the first Friday of the month and discusses addiction/toxicology cases in an interactive fashion featuring experts from addiction medicine, addiction psychiatry, and medical toxicology.

The American College of Medical Toxicology (ACMT) recurring "Addiction Toxicology Case Conference" series is co-hosted by the American Society of Addiction Medicine (ASAM). The co-hosted series is an interactive discussion of addiction toxicology cases and will feature ASAM and ACMT members, as well as guest experts. This series of sessions provides a comprehensive overview of COVID-19 resources and focuses on challenging cases to inform your practices during the pandemic.

The target audience for this introductory level activity includes: all members of the care team. 

This activity addresses the following ACGME Competencies: Patient Care, Medical Based Knowledge, Practice Based Learning.

Live webinars occur on the first Friday of every month, register for the live Case Conference here. You can access on-demand recordings of previous Case Conferences in the contents tab. 

Registration Rates

ASAM Learner TypeRate
ASAM Member$0
Non-Member$0
Associate Member$0
Resident Member*$0
Student Member*$0

*Residents, Fellows-in-training, Interns, and Students must join ASAM to receive a discounted registration rate. Click here to become an ASAM member. National and Chapter membership dues apply. There is no charge for Students to become a Member, but verification of student status is required.

Membership Question?  Call ASAM at 1.301.656.3920, email us, or view the ASAM website for more information.

Refunds & Cancellations

All ASAM e-Learning Center refund requests must be made in writing to Education@ASAM.org within 90 days of purchase. Those requesting refunds for courses that are in progress will receive partial refunds or e-Learning Center credit. Automatic full refunds will be made for any course with a live-course component that has been cancelled.

Registration Deadline: 08/09/2024

Instructions

  1. Click on the Content tab to select the 2020 or 2021 webinar series.
  2. Click on the Content tab again to view the sessions.
  3. Click the button Claim Medical Credits in the box titled Claim Certificate of Completion. Click the button View/Print Certificate to save or print your certificate. You can view/print your certificate at any time by visiting the ASAM e-Learning Center, clicking Dashboard, and clicking Transcript/Achievements.

Need Assistance?

For assistance logging in, accessing activities, claiming credit, or for other questions or concerns, please check the FAQ page or e-mail Education@ASAM.org

ASAM is proud to offer eSSENTIAL Accessibility to ensure our website is accessible and functional for all our learners while providing free assistive technology for people with the widest possible range of abilities.

 

  • 2020 ACMT/ASAM Addiction Toxicology Case Conferences

    Product not yet rated Contains 42 Component(s), Includes Credits

    This 10-hour, free series of on-demand case conferences focuses on the impact of COVID19, discusses challenging cases/opportunities given the rapidly changing landscape of treatment, and provides an overview of ASAM COVID19 resources.

    2020 ACMT/ASAM Addiction Toxicology Case Conferences

    On-Demand Webinars

    Overview

    This 10-hour, free series of on-demand case conferences focuses on the impact of COVID19, discusses challenging cases/opportunities given the rapidly changing landscape of treatment, and provides an overview of ASAM COVID19 resources.

    As the leader in developing clinical guidelines and standards in addiction medicine, ASAM takes its responsibility very seriously. Many providers and programs are urgently working to mitigate risks related to COVID-19. The American College of Medical Toxicology (ACMT) recurring "3rd Friday Addiction Toxicology Case Conference" series is co-hosted by the American Society of Addiction Medicine (ASAM). The co-hosted series is an interactive discussion of addiction toxicology cases and will feature ASAM and ACMT members, as well as guest experts. This series of sessions provides a comprehensive overview of COVID-19 resources and focuses on challenging cases to inform your practices during the pandemic. 

    This series is now available on-demand and recordings of Case Conferences are available in the contents tab. 

    The target audience for this introductory level activity includes: all members of the care team. 

    This activity addresses the following ACGME Competencies: Patient Care, Medical Based Knowledge, Practice Based Learning.

    Learning Objectives

    Upon completion, learners will be able to:

    1. Describe outcomes that lead to improvement in response perspectives on navigating challenges that arise during novel care delivery
    2. Explain methods to navigate challenges that arise utilizing telehealth and phone support
    3. Identify related changes in monitoring for patients treated for opioid use disorder and in novel settings
    4. Recognize medication availability for patients treated for opioid use disorder and in novel settings

    Registration Rates

    ASAM Learner TypeRate
    ASAM Member$0
    Non-Member$0
    Associate Member$0
    Resident Member*$0
    Student Member*$0

    *Residents, Fellows-in-training, Interns, and Students must join ASAM to receive a discounted registration rate. Click here to become an ASAM member. National and Chapter membership dues apply. There is no charge for Students to become a Member, but verification of student status is required.

    Membership Question?  Call ASAM at 1.301.656.3920, email us, or view the ASAM website for more information.

    Refunds & Cancellations

    All ASAM e-Learning Center refund requests must be made in writing to Education@ASAM.org within 90 days of purchase. Those requesting refunds for courses that are in progress will receive partial refunds or e-Learning Center credit. Automatic full refunds will be made for any course with a live-course component that has been cancelled.

    Registration Deadline: 12/31/2020

    Instructions

    1. Click on the Contents tab to begin this activity.
    2. Click the dates in the contents menu to view the sessions and presentation slides.
    3. Click Complete Post Test after completing each module to answer multiple choice questions. Participants will have 10 attempts to pass and must answer 2 out of 3 questions correctly.
    4. Click Complete Evaluation after competing module to provide valuable activity feedback. Scroll down on all questions as there may be answer options that expand past the size of the window.
    5. Click the button Claim Medical Credits in the box titled Claim Certificate of Completion. Click the button View/Print Certificate to save or print your certificate. You can view/print your certificate at any time by visiting the ASAM e-Learning Center, clicking Dashboard, and clicking Transcript/Achievements.

    Need Assistance?

    For assistance logging in, accessing activities, claiming credit, or for other questions or concerns, please check the FAQ page or e-mail Education@ASAM.org

    ASAM is proud to offer eSSENTIAL Accessibility to ensure our website is accessible and functional for all our learners while providing free assistive technology for people with the widest possible range of abilities.

    Moderators: 
      Timothy J. Wiegand, MD, FACMT, FAACT, DFASAM (ACMT/ASAM Expert) Director of Toxicology and of the Toxicology Consult Service, University of Rochester Medical Center, Rochester, NY 
      Gloria J. Baciewicz, MD, FASAM Director, Addiction Psychiatry Program (called Strong Recovery Addiction Psychiatry Program); Medical Director, Adult Ambulatory Program for Strong Health; Professor of Clinical Psychiatry, Department of Psychiatry, University of Rochester Medical Center, Rochester, NY 
    Session 1: Friday, April 15, 2020
    Speakers: 
      Gloria J. Baciewicz, MD Director, Addiction Psychiatry Program (called Strong Recovery Addiction Psychiatry Program); Medical Director, Adult Ambulatory Program for Strong Health; Professor of Clinical Psychiatry, Department of Psychiatry, University of Rochester Medical Center, Rochester, NY 

      Chris Bundy, MD, MPH
      Associate Medical Director, Washington Physicians Health Program, Seattle, WA 

      Paul H. Earley, MD, DFASAM
      Addiction Medicine Physician; President,  American Society of Addiction Medicine; President, Federation of State Physician Health Programs, Atlanta, GA 

      Michael Holland, MD, FEAPCCT, FAACT, FACOEM, FACMT, FACEP
      Clinical Professor in the Department of Emergency Medicine, State University of New York (SUNY), Upstate Medical University; Senior Medical Toxicologist, CTEH, Syracuse, NY 

      JoAn Laes, MD
      Addiction Medicine Physician, Hennepin Healthcare, Minneapolis, MN 

      Lewis Nelson, MD
      Professor and Chair of Emergency Medicine, Rutgers University, Newark, NJ 

      Jeanmarie Perrone, MD, FACMT
      Professor of Emergency Medicine at the Hospital of the University of Pennsylvania; Director, Division of Medical Toxicology and Addiction Medicine Initiatives, Department of Emergency Medicine, University of Pennsylvania; Founding Director, Penn Medicine Center for Addiction Medicine and Policy, Philadelphia, PA 

      Myra Rodriguez, PAC
      Affiliate Member of the American Society of Addiction Medicine (ASAM); Director of Medical Affairs Huther Doyle Chemical Dependency Treatment Program, Rochester, NY 

      Ed Salsitz, MD, DFASAM
      Associate Clinical Professor of Psychiatry, Mount Sinai School of Medicine, Mount Sinai and Beth Israel Hospitals, New York, NY
    Cases:
    1.  A colleague has identified some drug testing results from a professional monitoring program case and is requesting feedback.  
    2. A 31-year-old contacts an outpatient treatment program to receive treatment for opioid use disorder and has some challenges stabilizing via phone/telehealth contact.
    3. A detoxification facility was not able to admit a patient due to fever, cough, and presumed COVID19 positive test.  He is quarantined at a local hotel supported by county resources -a department of health representative has asked if 'ambulatory detox' for alcohol dependence could be arranged from an outpatient clinic to the hotel site supporting him
    4. A 44-year-old patient with a long history of opioid and stimulant use disorder has taken several doses of his  'two week' take-home quantity of methadone which he received due to COVID19 -he normally attends 6/7 days a week.  He is given naloxone by his partner and transported to the Emergency Department. 
    Session 2: Friday, May 15, 2020
    Speakers: 
      Gloria J. Baciewicz, MD (ASAM Expert)
      Director, Addiction Psychiatry Program (called Strong Recovery Addiction Psychiatry Program); Medical Director, Adult Ambulatory Program for Strong Health; Professor of Clinical Psychiatry, Department of Psychiatry, University of Rochester Medical Center, Rochester, NY

      Kenneth R. Conner, PsyD, MPH (Guest Expert)
      Co-Director, Center for the Study and Prevention of Suicide; Clinical Psychologist and Professor in Emergency Medicine and Psychiatry, University of Rochester Medical Center, Rochester, NY

      Robert K. Horowitz, MD (Guest Expert)
      Chief, Division of Palliative Care; Georgia and Thomas Gosnell Distinguished Professor in Palliative Care, University of Rochester Medical Center, Rochester, NY

      Ross Sullivan, MD (ACMT/ASAM Expert)
      Director of Medical Toxicology, Upstate University Hospital; Director, Upstate Emergency Medicine Opioid Bridge Clinic; Medical Director, Helio Health, Syracuse, NY

      Ingrid Vicas, MD (ACMT Expert)
      Clinical Associate Professor, Departments of Emergency Medicine, Internal Medicine, Physiology & Pharmacology, Cummings School of Medicine, University of Calgary, Alberta, Canada

      Melissa Weimer, DO, MCR, FASAM (ASAM Expert)
      Medical Director, Yale Addiction Medicine Consult Service (YAMCS); Assistant Professor, Yale School of Medicine, New Haven, CT
    Cases:
    1. A 58-year-old M with opioid use disorder treated with 8/2 mg buprenorphine/naloxone two films/day is diagnosed with nephrolithiasis after an emergency trip to the hospital. 
    2. A 60-year-old F who, under normal circumstances, receives 2 weeks RX but since the COVID-19 pandemic has received 30 days RX to minimize travel and contact with the pharmacy. She calls 8 days early reporting she is "out."
    3. A 22-year-old F with alcohol use disorder, who has increased her drinking since the COVID-19 pandemic, reaches out for help. 
    Session 3: Friday, June 19, 2020
    Speakers: 
      Alexandra Amaducci, DO (ACMT Expert)
      Emergency Medicine Physician, Lehigh Valley Hospital Muhlenberg, Bethlehem, PA

      Matthew D. Cook, DO (ACMT Expert)
      Chief, Division of Medical Toxicology, Department of Emergency And Hospital Medicine, Lehigh Valley Health Network, Allentown, PA

      Brian Hurley, MD, MBA, DFASAM (ASAM Expert)
      Director of Addiction Medicine, Los Angeles County Department of Health Services, Los Angeles, CA

      Ryan J. Magnuson, DO (Guest Expert)
      Assistant Professor, Department of Medicine, Pulmonary Diseases and Critical Care, University of Rochester Medical Center, Rochester, NY

      Kelly S. Ramsey, MD, MPH, MA, FACP (ASAM Expert)
      President-Elect, New York Society of Addiction Medicine (NYSAM)

      Henry D. Swoboda, MD (ACMT/ASAM Expert)
      Assistant Professor, Department of Emergency Medicine, Rush University Medical College, Chicago, IL
    Cases:
    1. A 47-year-old M furloughed during COVID19 has been drinking heavier and after trying to ‘self-detox’ presents to the ED with tachycardia, hypertension, tremors and hallucinations. 
    2. An Intensivist asks if there is utility in using buprenorphine and some ‘other’ techniques for some of the severe, critically ill, COVID19 patients that often require prolonged sedation and analgesia.
    3. A 29-year-old F with opioid and stimulant use disorder and IVDU-associated severe aortic valve endocarditis with perforation and severe aortic regurgitation is hospitalized during COVID19 – she is not complying with treatments/regimens critical to success with valve replacement. 
    Session 4: Friday, July 17, 2020
    Speakers: 
      Carolyn W. Greer, MS, MD, FACOG, FASAM(ASAM Expert)
      Addiction Medicine Specialist, Otis R. Bowen Center for Human Services; Medical Director, Bowen Recovery Center, Fort Wayne, IN

      Jonathan C. Lee, MD, MBA, FASAM, FACP, FAPA (ASAM Expert)
      Addiction Medicine Physician, Medical Director, The Farley Center, Williamsburg, VA; Community Assistant Professor, Eastern Virginia Medical School, Norfolk, VA

      Lewis Nelson, MD, FACMT (ACMT Expert)
      Chair of the Department of Emergency Medicine, Rutgers New Jersey Medical School, Newark, NJ

      Alaina R. Steck, MD, FACMT (ACMT Expert)
      Assistant Professor of Emergency Medicine, Emory University School of Medicine, Atlanta, GA

    Cases:
    1. A 60 -year-old administrator requests ambulatory detoxification for combined alcohol and sedative dependence during COVID19. He has several previous detoxification and treatment episodes that have required aggressive treatment regimens to get his withdrawal under control in the past. 
    2. A Professional Health Program identifies a physician who is dependent on kratom and has considerations about treatment regimen and drug testing/monitoring.
    3. A 31-year-old F, 30 weeks pregnant, is found unconscious behind an abandoned house. She has had limited prenatal care and reportedly been using substantial amounts of ‘street Xanax,” fentanyl, alcohol and cocaine. She is intubated for airway and breathing support and is waking up agitated, requiring “huge doses of sedatives.” The Intensivists and OB are asking for assistance managing her dependence, withdrawal and sedation requirements.

    Session 5: Friday, August 21, 2020
    Speakers: 
      Lewis Nelson, MD, FACMT (ACMT Expert)
      Chair of the Department of Emergency Medicine, Rutgers New Jersey Medical School, Newark, NJ

      Neil S. Seligman, MD, MS (Guest Expert)
      Director, Labor & Delivery, Highland Hospital; Associate Professor, Department of Obstetrics and Gynecology, University of Rochester Medical Center, Rochester, NY   

      Jeffrey Selzer, MD, DFASAM, DFAPA (ASAM Expert)
      Medical Director, Committee for Physician Health, Medical Society of the State of New York Director, Physician’s Resource Network, Northwell Health, Albany, NY

      Norman W. Wetterau, MD, FAAFP, FASAM (ASAM Expert)
      Addiction Medicine Specialist, Tricounty Family Medicine; Clinical Assistant Professor of Family Medicine, University of Rochester School of Medicine, Rochester, NY
    Cases:
    1. A 27-year-old M presents to the ED with cellulitis from IVDU. He had relapsed with fentanyl and cocaine in April 2020 as a month Rx his pharmacy changed to delivering all medication early in the COVID-19 pandemic and his Rx was “stolen”. He’d gone without buprenorphine/naloxone for several days and, unable to contact his clinic, he’d used heroin/fentanyl then was, “just back at it....” Interested in getting back into treatment and restarting buprenorphine/naloxone as soon as possible.
    2. A 38-year-old M is interested in getting help for stimulant and opioid use but the inpatient program he’d wanted to enter is “holding admits due to a COVID19 outbreak,” and there is a two-week wait for either telemedicine or on-site evaluation at the county treatment program in a rural part of the state. After 3 days of trying to “detox at home,” he presents to the Emergency Department because, “I didn’t know what else to do.” Patient is in florid opioid withdrawal with rhinorrhea, tearing, yawns repeatedly, has vomiting and diarrhea and is extremely anxious and restless.
    Session 6: Friday, September 4, 2020
    Speakers: 
      Michael Hodgman, MD (ACMT Expert)
      Assistant Professor of Emergency Medicine, Upstate Medical University, Syracuse, NY

      John A. Hopper, MD, DFASAM, FAAP, FACP (ASAM Expert)
      Clinical Professor, Wayne State University School of Medicine, Detroit, MI

      JoAn Laes, MD (ACMT Expert)
      Attending Physician, Division of Addiction Medicine, Hennepin County Medical Center, Minneapolis, MN

      Barry K. Logan, PhD, F-ABFT (Guest Expert)
      Executive Director, Center for Forensic Science Research and Education, Fredric Rieders Family Renaissance Foundation; Senior Vice President of Forensic Sciences, Chief Scientist, NMS Labs, Willow Grove, PA

    Cases:
    1. This case features a patient with combined opioid and sedative use disorder who has stabilized on buprenorphine without opioid use for years but has continued to use benzodiazepines and other sedatives.
    2. A 44-year-old F is found acting bizarre and agitated. She has psychomotor agitation and bizarre 'rocking' movements and is markedly tachycardic and sweating profusely. She is on probation and has numerous legal issues related to substance use.
    3. This case involves discussion of the different types of synthetic opioids found in the heroin supply and differences in pharmacology that would, in particular, impact the ability to start buprenorphine.
    Session 7: Friday, October 2, 2020
    Speakers: 
      Barry K. Logan, PhD, F-ABFT (Guest Expert)
      Executive Director, Center for Forensic Science Research and Education, Fredric Rieders Family Renaissance Foundation; Senior Vice President of Forensic Sciences, Chief Scientist, NMS Labs, Willow Grove, PA

      Soumya L. Pandalai, MD, FACP, FASAM (ACMT Expert)
      Clinical Assistant Professor, University of Arizona College of Medicine; Banner University Medical Center Phoenix (BUMCP) Addiction Medicine, Phoenix, AZ

      Andrew Stolbach, MD, MPH, FAACT, FACEP, FACMT (ACMT Expert)
      Associate Professor of Emergency Medicine, Department of Emergency Medicine, Johns Hopkins University School of Medicine; Johns Hopkins Hospital, Baltimore, MD
    Cases:
    1. This case will feature discussion of drug-induced agitated delirium with experts dissecting the mechanism and common course of events that occur in the most severe type of agitated delirium, often referred to as Excited Delirium Syndrome. Myths and misperceptions in care of patients with agitation and delirium will be addressed, as will discussion of the appropriate use of sedation and importance of cooling in these patients. Case discussion will also include an overview of causes of agitated delirium, including the types of drugs involved as well as non-drug mechanisms.  
    2. This case includes an example of how an outpatient clinical addiction medicine program's clinical services were impacted by protests related to the death of George Floyd, and serves to highlight the need for flexibility, including telemedicine support, in order to rapidly respond to stresses at various levels of addiction care brought on by COVID-19 and other factors. Social and racial disparities in addiction medicine, exacerbated by COVID-19, will also be discussed to provide examples of successful methods used to keep access to critical services and support, including critical medications to treat opioid use disorder in particular.  
    Session 8: Friday, November 6, 2020
    Speakers: 
      Derek Eisnor, MD (ACMT/ASAM Expert)
      Medical Officer, Division of Clinical Development, Biomedical Advanced Research and Development Authority (BARDA), Office of the Assistant Secretary for Preparedness and Response, U.S. Department of Health and Human Services, Washington, DC

      Lewis S. Nelson, MD, FACMT, FASAM (ACMT/ASAM Expert)
      Professor and Chair of Emergency Medicine, Rutgers New Jersey Medical School, Newark, NJ

      Natalie Neumann, MD (Guest Expert)
      Clinical Instructor, Department of Emergency Medicine, Yale School of Medicine, Yale University, New Haven, CT

      Marc T. Swogger, PhD (Guest Expert)
      Associate Professor, Department of Psychiatry, Unversity of Rochester Medical Center, Rochester, NY
    Cases:
    1. A 28-year-old F with polysubstance dependence, including a history of heroin/fentanyl, cocaine, cannabis, prescription benzodiazepines and stimulant (both amphetamines and methylphenidate) use, is currently receiving buprenorphine/naloxone in an outpatient addiction treatment program. She is interested in attending a “ketamine clinic” for depression.” She had undergone a “very positive” ayahuasca experience a few years prior, traveling to Brazil to do so, but it wore off and she is hoping her response to ketamine will be similar but more sustained. 
    2. A 32-year-old F with alprazolam dependence is found unresponsive after insufflating “some Percocets.” Transient hemodynamic response to IN naloxone but she does not wake up. In order to appropriately ventilate and control agitation, she requires 250 mcg/hour fentanyl, 8 mg/hour midazolam and 2 mg/kg/minutes of ketamine. Also, shortly after admission, the ICU team is contacted by the patient's mother who says she’d been informed that her daughter had been in contact with a person who’d been diagnosed with COVID-19.  
    Session 9: Friday, December 4, 2020
    Speakers: 
      Lewis S. Nelson, MD, FACMT, FASAM (ACMT/ASAM Expert)
      Professor and Chair of Emergency Medicine, Rutgers New Jersey Medical School, Newark, NJ

      Cara Poland, MD, M.Ed, FACP, DFASAM  (ASAM Expert)
      Assistant Professor, College of Human Medicine, Michigan State University, Grand Rapids, MI

      Ross Sullivan, MD (ACMT/ASAM Expert)
      Director of Medical Toxicology, Upstate University Hospital; Director, Upstate Emergency Medicine Opioid Bridge Clinic; Medical Director, Helio Health, Syracuse, NY
    Cases:
    1. A 26-year-old F with opioid use disorder ‘reconnects’ with an outpatient treatment program “to get back on Suboxone and then get the shot.” She has a history of fentanyl use disorder with use, despite Rx of buprenorphine/naloxone. Also, UDS showed her to stop taking, or only intermittently take, the buprenorphine around her fentanyl use. At the start of COVID-19, the plan was to have sufficient obs doses and on-site dosing to safely give the SC buprenorphine, but she didn’t follow-up. “Now I’m ready.” This case features discussion of buprenorphine induction and stabilization in order to safely give the SC buprenorphine monthly injection. Drug testing during COVID-19 as well as supporting challenging patients with limited ‘on-site’ resources will be discussed. On the on-site obs dose, the patient was caught taking a piece of buprenorphine/naloxone film pre-wrapped with cellophane, which she reported “was an accident. I had it open and didn’t want to lose it, so I wrapped it up.” 
    2. A 27-year-old F and mother of 3-year-old with Autism has been taking buprenorphine/naloxone but struggles with heavy crack cocaine use. Her partner is also struggling with cocaine and there have been several domestic disturbance calls as well as CPS calls to their residence. Counseling appointments have been challenging to make and, apparently, quite a few of the “early intervention” appointments for her son have been missed. CPS is asking for drug testing results. COVID-19 cases are increasing dramatically in the area.

    Please Note: CME is available for the ACMT webinars between April 2020 and January 8, 2021. Certificates of attendance are available for Case Conferences held after January 8, 2021

    CME, CE, CEU and Other Credit Types

    ACCME Accredited with Commendation

    ACCME Accreditation Statement
    The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    AMA Credit Designation Statement
    The American Society of Addiction Medicine designates this enduring material for a maximum of 10 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    NAADAC, the Association for Addiction Professionals
    This activity has been approved by the American Society of Addiction Medicine, as a NAADAC Approved Education Provider, for educational credits. NAADAC Provider #295, ASAM is responsible for all aspects of the programming.

    California Association for Drug/Alcohol Educators (CAADE)
    This educational program is approved by CAADE: #CP40 999 1222.

    California Association of DUI Treatment Centers (CADTP)
    This educational program is approved by CADTP: #205.

    California Consortium of Addiction Programs and Professionals (CCAPP)
    This educational program is approved by CCAPP: #OS-20-330-1222.

    Continuing Education Credits (CEUs)
    Non-physician participants will receive a certificate of attendance upon completion of the activity and an online evaluation confirming their participation. Participants should submit his/her certificate of attendance to their professional organization/institute.

    Maintenance of Certification (MOC) or Continuing Certification Programs (CCP)

    American Board of Preventive Medicine (ABPM)
    The American Board of Preventive Medicine (ABPM) has approved this activity for a maximum of 10 credits towards ABPM MOC Part II requirements.

    American Board of Anesthesiology (ABA)
    This activity contributes to the CME component of the American Board of Anesthesiology’s redesigned Maintenance of Certification in Anesthesiology TM (MOCA®) program, known as MOCA 2.0®.

    American Board of Pediatrics (ABP)
    Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn a maximum of 1 MOC point in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.

    American Board of Internal Medicine (ABIM)
    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 10 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credits.

    American Board of Psychiatry and Neurology (ABPN)
    Successful completion of this CME activity can be used to satisfy the American Board of Psychiatry and Neurology’s (ABPN) CME requirement for Maintenance of Certification program. 

    American Board of Addiction Medicine (ABAM)
    Successful completion of this activity can be used to satisfy the American Board of Addiction Medicine (ABAM) Tmoc credit requirements.

    Disclosure Information

    In accordance with disclosure policies of ASAM and the ACCME, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all CME activities. These policies include mitigating all possible relevant financial relationships with ineligible companies for the Planning Committees and Presenters. All activity Planning Committee members and Presenters have disclosed relevant financial relationship information. The ASAM CME Committee has reviewed these disclosures and determined that the relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity.

  • 2021 ACMT/ASAM Addiction Toxicology Case Conferences

    Contains 29 Component(s), Includes Credits

    This free series of live and on-demand webinars occurs on the first Friday of the month and discusses addiction/toxicology cases in an interactive fashion featuring experts from addiction medicine, addiction psychiatry, and medical toxicology.

    2021 ACMT/ASAM Addiction Toxicology Case Conferences

    Live & On-Demand Webinars

    Overview

    This free series of live and on-demand webinars occurs on the first Friday of the month and discusses addiction/toxicology cases in an interactive fashion featuring experts from addiction medicine, addiction psychiatry, and medical toxicology.

    The American College of Medical Toxicology (ACMT) recurring "3rd Friday Addiction Toxicology Case Conference" series is co-hosted by the American Society of Addiction Medicine (ASAM). The co-hosted series is an interactive discussion of addiction toxicology cases and will feature ASAM and ACMT members, as well as guest experts. 

    Live webinars occur on the first Friday of every month, register for the live Case Conference here. You can access on-demand recordings of previous Case Conferences in the contents tab. 

    The target audience for this introductory level activity includes: all members of the care team. 

    This activity addresses the following ACGME Competencies: Patient Care, Medical Based Knowledge, Practice Based Learning.

    Please Note: CME is available for the ACMT webinars between April 2020 and January 8, 2021. Certificates of attendance are available for Case Conferences held after January 8, 2021.

    Registration Rates

    ASAM Learner TypeRate
    ASAM Member$0
    Non-Member$0
    Associate Member$0
    Resident Member*$0
    Student Member*$0

    *Residents, Fellows-in-training, Interns, and Students must join ASAM to receive a discounted registration rate. Click here to become an ASAM member. National and Chapter membership dues apply. There is no charge for Students to become a Member, but verification of student status is required.

    Membership Question?  Call ASAM at 1.301.656.3920, email us, or view the ASAM website for more information.

    Refunds & Cancellations

    All ASAM e-Learning Center refund requests must be made in writing to Education@ASAM.org within 90 days of purchase. Those requesting refunds for courses that are in progress will receive partial refunds or e-Learning Center credit. Automatic full refunds will be made for any course with a live-course component that has been cancelled.

    Registration Deadline: 08/16/2024

    Instructions

    1. Click on the Contents tab to begin this activity.
    2. Click the dates in the contents menu to view the sessions and presentation slides.
    3. Click the button Claim Medical Credits in the box titled View Certificate of Completion. Click the button View/Print Certificate to save or print your certificate. You can view/print your certificate at any time by visiting the ASAM e-Learning Center, clicking Dashboard, and clicking Transcript/Achievements.

    Need Assistance?

    For assistance logging in, accessing activities, claiming credit, or for other questions or concerns, please check the FAQ page or e-mail Education@ASAM.org

    ASAM is proud to offer eSSENTIAL Accessibility to ensure our website is accessible and functional for all our learners while providing free assistive technology for people with the widest possible range of abilities.

    Moderators: 
      Timothy J. Wiegand, MD, FACMT, FAACT, DFASAM (ACMT/ASAM Expert) 
      Director of Toxicology and of the Toxicology Consult Service, University of Rochester Medical Center, Rochester, NY 
      Gloria J. Baciewicz, MD, FASAM 
      Director, Addiction Psychiatry Program (called Strong Recovery Addiction Psychiatry Program); Medical Director, Adult Ambulatory Program for Strong Health; Professor of Clinical Psychiatry, Department of Psychiatry, University of Rochester Medical Center, Rochester, NY 
    Friday, January 8, 2021 ACMT/ASAM Addiction Toxicology Case Conference
    Speakers: 
      Arianna Sampson Campbell, PA-C (Guest Expert)
      Director, Co-Principal Investigator, California Bridge, Placerville, CA

      Frank J. Edwards, MD, FACEP (Guest Expert)
      GME Research Director, Associate Designated Institutional Official, Arnot Health Graduate Medical Education, Arnot Ogden Medical Center, Elmira, NY

      Eric J. Hill, CADC-I (Guest Expert)
      Substance Use Navigator, Emergency Department, Marshall Medical Center, Placerville, CA

      Nicholas Nacca, MD (ACMT Expert)
      Assistant Professor Emergency Medicine, University of Rochester Medical Center, Rochester, NY

      Ross Sullivan, MD (ACMT/ASAM Expert)
      Director of Medical Toxicology, Upstate University Hospital; Director, Upstate Emergency Medicine Opioid Bridge Clinic; Medical Director, Helio Health, Syracuse, NY
    Cases:
    1. A 27-year-old M presents to the ED with cellulitis from IVDU. He had relapsed with fentanyl and cocaine in April 2020 as a month Rx his pharmacy changed to delivering all medication early in the COVID-19 pandemic and his Rx was “stolen”. He’d gone without buprenorphine/naloxone for several days and, unable to contact his clinic, he’d used heroin/fentanyl then was, “just back at it....” Interested in getting back into treatment and restarting buprenorphine/naloxone as soon as possible.
    2. A 38-year-old M is interested in getting help for stimulant and opioid use but the inpatient program he’d wanted to enter is “holding admits due to a COVID19 outbreak,” and there is a two-week wait for either telemedicine or on-site evaluation at the county treatment program in a rural part of the state. After 3 days of trying to “detox at home,” he presents to the Emergency Department because, “I didn’t know what else to do.” Patient is in florid opioid withdrawal with rhinorrhea, tearing, yawns repeatedly, has vomiting and diarrhea and is extremely anxious and restless.
    Friday, March 5, 2021 ACMT/ASAM Addiction Toxicology Case Conference
    Speakers: 
      Nancy Onisko, DO, FACEP (Guest Expert)
      Assistant Professor of Emergency Medicine, Faculty in Medical Toxicology, University of Texas Southwestern Medical Center; Co-Director, Perinatal Intervention Program, Parkland Hospital and Health System, Dallas, TX
      Neil S. Seligman, MD, MS (Guest Expert)
      Director, Labor & Delivery, Strong Memorial Hospital; Associate Professor, Division of Maternal- Fetal Medicine, University of Rochester Medical Center, Rochester, NY
      Tricia Wright, MD, MS, FACOG, DFASAM (ASAM Expert)
      Professor, Department of Obstetrics, Gynecology and Reproductive Sciences, School of Medicine, University of California San Francisco, San Francisco, CA
    Cases:
    1. A 29-year-old G2P10012 female delivers a 7 lb 2.8 oz baby boy at 38 3/7 weeks. Apgars at 1 min and 5 min 7 and 8. At 33 hours the newborn is noticed to be “jittery, have increased tone, very spitty” and has 6 x stools and 7 x emesis. Scoring 11 and 9 for NAS and transferred the following day to a tertiary care center. Mother has been diagnosed with BPAD and was taking a variety of medications, including venlafaxine, throughout pregnancy. No urine or meconium testing done. Toxicology consulted as patient’s NAS have increased to >15 on day 3 despite use of clonidine 1 mcg/kg/6 hours and phenobarbital 2.5 mg/kg/day. Is this SNRI withdrawal/discontinuation? How do you proceed?
    2. A 27-year-old female with a long history of polydrug dependence, including opioids and stimulants, had been staying in a local YWCA-associated program for women in recovery. She was prescribed 8/2 mg buprenorphine/naloxone SL TID and had been taking that for 6 months. She was also prescribed gabapentin 800 mg PO TID (though reported taking extra at times). Other meds include clonidine (taken intermittently). After delivery, her baby is scoring much higher than anticipated, despite treatment for NAS, and the NICU consults Toxicology for evaluation regarding possible gabapentin and other substance withdrawal as well.
    Friday, April 2, 2021 ACMT/ASAM Addiction Toxicology Case Conference
    Speakers: 
      Erik Gunderson, MD, DFASAM (ASAM Expert)
      Director, Center for Wellness and Change; Associate Professor, Department of Psychiatry and Neurobehavioral Sciences, University of Virginia School of Medicine, Charlottesville, VA
      Barry K. Logan, PhD, F-ABFT (Guest Expert)
      Executive Director, Center for Forensic Science Research and Education, Fredric Rieders Family Renaissance Foundation; Senior Vice President of Forensic Sciences, Chief Scientist, NMS Labs, Willow Grove, PA
      Michael Weaver, MD, DFASAM (ASAM Expert)
      Medical Director, Center for Neurobehavioral Research on Addiction; Professor of Psychiatry, Department of Psychiatry and Behavioral Sciences, McGovern Medical School, The University of Texas Health Sciences Center at Houston, Houston, TX
    Cases:
    1. A 31-year-old M with opioid use disorder and extensive history of synthetic cannabinoid dependence re-engages with an outpatient treatment program during COVID-19. He reports, “trouble restarting the Suboxone because of fentanyl,” and that he cannot stop using K2 because he has withdrawal when he does.
    2. A 25-year-old M is brought to the ED from jail after turning himself in. His significant other had encouraged him to do so for warrant, partly because he needed to stop using K2 and “sort everything out for a while.” During a search, several balloons containing a substance are discovered and two are recovered by the guards; however, one is grabbed and swallowed by the individual. He is brought to the ED and, shortly after arrival, has a seizure. His UDS is positive for fentanyl and negative for everything else.
    Friday, May 7, 2021 ACMT/ASAM Addiction Toxicology Case Conference
    Speakers: 
      Alexandra M. Amaducci, DO (ACMT Expert)
      Medical Toxicology Fellow, Emergency Medicine Physician, Lehigh Valley Health Network, Bethlehem, PA
      John A. Hopper, MD, DFASAM, FAAP, FACP (ASAM Expert)
      Recovery Medicine Physician, Integrated Health Associates, Ann Arbor, MI Clinical Professor, Wayne State University School of Medicine, Detroit, MI Clinical Professor, Central Michigan University, Mount Pleasant, MI
      Daniel J. Sessions, MD (ACMT Expert)
      Medical Toxicologist, Emergency Care Consultants; Minnesota Poison Control Systems, Minneapolis, MN
    Cases:
    1. A 24-year-old M reports hearing loss and tinnitus after he is awoken from overdose from EMS-administered naloxone after using a “Research Chemical” he’d ordered from the Internet called MT-45.
    2. A 28-year-old M self-proclaimed ‘psychonaut’ has been using a ‘nootropic’ called tianeptine but reports, “it’s gotten out of hand.” He describes difficulty in stopping use and using in increasing amounts. When he tries to stop, he has diarrhea, chills and “shock-like feelings like static electricity but continuous.”
    Friday, June 4, 2021 ACMT/ASAM Addiction Toxicology Case Conference
    Speakers: 
      JoAn Laes, MD, FACMT, FASAM (ACMT/ASAM Expert)
      Attending Physician, Division of Addiction Medicine, Hennepin County Medical Center, Minneapolis, MN
      Barry K. Logan, PhD, F-ABFT (Guest Expert)
      Executive Director, Center for Forensic Science Research and Education, Fredric Rieders Family Renaissance Foundation; Senior Vice President of Forensic Sciences, Chief Scientist, NMS Labs, Willow Grove, PA
      Lewis Nelson, MD, FACMT, FASAM (ACMT/ASAM Expert)
      Professor and Chair, Department of Emergency Medicine; Chief, Division of Medical Toxicology, Rutgers New Jersey Medical School, Newark, NJ
      Rachel Wightman, MD (ACMT Expert)
      Director, Medical Toxicology Education; Assistant Professor, Department of Emergency Medicine, Warren Alpert Medical School, Brown University, Providence, RI
    Cases:
    1. "I used to be able to take an 8 mg ‘Sub’ 24 hours after stopping. Now here I am in the ED!” A 24-year-old with panic, tearing, nausea, vomiting, and repeated yawning just can’t stop moving around after trying to restart buprenorphine/naloxone after 2 weeks of heavy heroin use.
    2. 3 doses of 4 mg IN naloxone in rapid succession in a patient down from presumed heroin OD is in severe withdrawal 20 minutes after rolls into the ED.
    3. 3 doses of 4 mg IN naloxone in rapid succession in a patient down from presumed heroin OD is in severe withdrawal 20 minutes after rolls into the ED.
    Friday, July 2, 2021 ACMT/ASAM Addiction Toxicology Case Conference
    Speakers: 
      Richard S. Dent, MD (Guest Expert)
      Medical Director, Chemical Dependency Services, Rochester Regional Health; Clinical Senior Instructor (Voluntary), Department of Family Medicine, University of Rochester Medical Center, Rochester, NY
      Robert K. Horowitz, MD (Guest Expert)
      Chief, Division of Palliative Care; Georgia and Thomas Gosnell Distinguished Professor in Palliative Care, University of Rochester Medical Center, Rochester, NY
      Thomas St. John, CRPA-P (Guest Expert)
      Peer Advocate, Delphi Rise, Rochester, NY
      Ross Sullivan, MD (ACMT/ASAM Expert)
      Director, Medical Toxicology Education; Assistant Professor, Department of Emergency Medicine, Warren Alpert Medical School, Brown University, Providence, RI
    Cases:
    1. Coordinating treatment for a 57-year-old patient with head and neck cancer, and severe substance use disorder.
    2. 3 doses of 4 mg IN naloxone in rapid succession in a patient down from presumed heroin OD is in severe withdrawal 20 minutes after rolls into the ED.
    3. Balancing harm reduction strategies for a patient with severe opioid and stimulant use disorder who repeatedly requests restarting buprenorphine films from a detox setting.
    Friday, August 6, 2021 ACMT/ASAM Addiction Toxicology Case Conference
    Speakers: 
      Joseph D’Orazio, MD, FAAEM, FACMT (ACMT Expert)
      Associate Professor of Clinical Emergency Medicine; Director, Division of Medical Toxicology, Department of Emergency Medicine, Lewis Katz School of Medicine, Temple University, Philadelphia, PA.
      Jeanmarie Perrone, MD, FACMT (ACMT Expert)
      Professor, Department of Emergency Medicine; Director, Division of Medical Toxicology and Addiction Medicine Initiatives, Perelman School of Medicine; Director, Penn Center for Addiction Medicine and Policy, University of Pennsylvania, Philadelphia, PA.
      Kelly S. Ramsey, MD, MPH, MA, FACP, FASAM (ASAM Expert)
      Chief of Medical Services, New York State Office of Addiction Services and Supports, Albany, NY. Mayra Rodriguez Beltran, PA-C (Guest Expert)
      Director of Medical Services, Huther Doyle, Rochester, NY.
      Edwin A. Salsitz, MD, DFASAM (ASAM Expert)
      Associate Clinical Professor of Psychiatry, Icahn School of Medicine, Mount Sinai Beth Israel, New York, NY.
    Cases:
    1. Xylazine in the illicit drug supply and a cluster of overdose deaths.
    2. Vaccine hesitancy in substance use disorder treatment.

    Friday, September 3, 2021 ACMT/ASAM Addiction Toxicology Case Conference
    Speakers: 
    JoAn Laes, MD, FACMT, FASAM (ACMT/ASAM Expert)
    Attending Physician, Division of Addiction Medicine, Hennepin County Medical Center, Minneapolis, MN
    Kelly S. Ramsey, MD, MPH, MA, FACP, FASAM (ASAM Expert)
    Chief of Medical Services, New York State Office of Addiction Services and Supports, Albany, NY.
    Mayra Rodriguez Beltran, PA-C (Guest Expert)
    Director of Medical Services, Huther Doyle, Rochester, NY.
    Cases:
    1. A 30-year-old male wants to stop drinking but not completely. Looking at the use of PRN naltrexone tablets before going out to events with alcohol.
    2. Home dosing of phenobarbital, different models of 'ambulatory detox' that incorporate telemedicine visits, and when to add anti-craving medications.
    Friday, October 1, 2021 ACMT/ASAM Addiction Toxicology Case Conference
    Speakers: 
      Timothy Carnes, MD (ASAM Expert)
      Director of Toxicology and of the Toxicology Consult Service, University of Rochester Medical Center, Rochester, NY.
      Joseph Carpenter, MD (ACMT Expert)
      Assistant Professor, Department of Emergency Medicine, Emory University School of Medicine, Atlanta, GA.
      Zachary Illg, DO (Guest Expert)
      Medical Toxicology Fellow, Department of Emergency Medicine, Emory University School of Medicine, Atlanta, GA. Alaina Steck, MD (ACMT Expert)
      Associate Professor, Department of Emergency Medicine, Emory University, Medical Director, Grady Medication-Assisted Opioid Treatment (MAOT) Clinic, Assistant Medical Director, Georgia Poison Center, Atlanta, GA.
    Cases:
    1. 23-year-old male with use of 7 grams a day of phenibut with anxiety, tremors, and sweats with any attempts to taper. Looking for a withdrawal protocol at a medically supervised detoxification level of care for 7-10 days.
    2. Patient with use of kratom, alcohol, and sedatives (intermittent benzodiazepines) has a seizure after brief relapse with alcohol about a week after leaving detox for alcohol and sedative use. Kratom use was not addressed during detox.

    Please Note: CME is available for the ACMT webinars between April 2020 and January 8, 2021. Certificates of attendance are available for Case Conferences held after January 8, 2021.

    CME, CE, CEU and Other Credit Types

    ACCME Accredited with Commendation

    ACCME Accreditation Statement

    The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    This activity does not include any credits.  Learners do have the ability to download a certificate of completion.

    Disclosure Information

    In accordance with disclosure policies of ASAM and the ACCME, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all CME activities. These policies include mitigating all possible relevant financial relationships with ineligible companies for the Planning Committees and Presenters. All activity Planning Committee members and Presenters have disclosed relevant financial relationship information. The ASAM CME Committee has reviewed these disclosures and determined that the relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity.